The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Sep. 04, 2018

Filed:

Jan. 20, 2015
Applicant:

Merck Sharp & Dohme Corp., Rahway, NJ (US);

Inventors:

Richard Berger, Harleysville, PA (US);

Timothy A. Blizzard, Princeton, NJ (US);

Brian T. Campbell, Burlington, NJ (US);

Helen Y. Chen, Marlboro, NJ (US);

John S. Debenham, Scotch Plains, NJ (US);

Sunita V. Dewnani, Secaucus, NJ (US);

Byron Dubois, New York, NY (US);

Candido Gude, Staten Island, NY (US);

Zack Zhiqiang Guo, Morganville, NJ (US);

Bart Harper, New York, NY (US);

Zhiyong Hu, Livingston, NJ (US);

Songnian Lin, Holmdel, NJ (US);

Ping Liu, Westfield, NJ (US);

Ming Wang, Belle Mead, NJ (US);

Feroze Ujjainwalla, Hoboken, NJ (US);

Jiayi Xu, Marlboro, NJ (US);

Libo Xu, Bridgewater, NJ (US);

Rui Zhang, Plainsboro, NJ (US);

Assignee:

Merck Sharp & Dohme Corp., Rahway, NJ (US);

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
C07D 413/14 (2006.01); C07D 417/14 (2006.01); C07D 413/12 (2006.01); C07D 471/04 (2006.01); C07D 401/12 (2006.01);
U.S. Cl.
CPC ...
C07D 413/14 (2013.01); C07D 401/12 (2013.01); C07D 413/12 (2013.01); C07D 417/14 (2013.01); C07D 471/04 (2013.01);
Abstract

The compounds of Formula I act as MGAT2 inhibitors and can be useful in preventing, treating or acting as a remedial agent for hyperlipidemia, diabetes mellitus and obesity.


Find Patent Forward Citations

Loading…